Anavex Life Sciences Corp (AVXL)

[Doc328]

AVXL did not raise their value enough with the poorly designed 2a so partnering now would be disappointing as terms would be poor. My strategy is to accept a roll of the dice with PDD (with some trading around the edges). Success in the PDD trial which is large enough enough and well designed has potential to get some good terms with enough upfront money to develop the rest of the pipeline and make shareholders smile. IMO, Rett studies are too small and too short to excite BP when results are in.